Actively Recruiting
Topical Treatment for TMJ Arthralgia
Led by University of the Pacific · Updated on 2024-12-11
90
Participants Needed
1
Research Sites
147 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to evaluate the efficacy of topical 2.5% hydrocortisone in TMJ arthralgia. The main questions it aims to answer are: * How does pain reduction compare? * How does improvement in jaw function limitation compare? * How do side effects compare? Participants will * On day 1 be examined and report their pain level and jaw function limitation * On days 1-21, apply their cream four times a day * On day 21, report their pain level, jaw function limitation, compliance with instructions, and side effects. Researchers will compare topical 2.5% hydrocortisone and topical 1% diclofenac to see if efficacy and side effects differ.
CONDITIONS
Official Title
Topical Treatment for TMJ Arthralgia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Arthralgia of at least one TMJ lasting at least 3 days
You will not qualify if you...
- Presence of systemic pain conditions
- Past adverse reaction to steroids
- Current steroid use
- Steroid use within the past several months
- Use of muscle relaxants during the study
- Use of a new night guard during the study or within 1 month before starting the study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Arthur A. Dugoni School of Dentistry, University of the Pacific
San Francisco, California, United States, 94103
Actively Recruiting
Research Team
A
Andrew Young, DDS, MSD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here